Frédéric MOURLANE
6Patents
1h-index
18Co-inventors
40Inventor score
Filing activity: Aug 24, 2010 → Jul 26, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9593314B2 | Binding molecules with antitumoral activity | Chemistry; Metallurgy | 1 | Active |
| US9468662B2 | Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases | Human Necessities | 0 | Active |
| US9376477B2 | IL-17 binding compounds and medical uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11638752B2 | Viral vector constructs for expression of genetic adjuvants activating the STING pathway | Emerging Cross-Sectional Technologies | 0 | Active |
| US12209243B2 | Aptamer-based CAR T-cell switch | Chemistry; Metallurgy | 0 | Active |
| US11674153B2 | Viral vector constructs for expression of genetic adjuvants activating the CD40 and STING pathways | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.